Use and outcomes of antihypertensive medication treatment in the US hypertensive population: A gender comparison

Shakir Ullah ¹ , Shahbaz Khan ² , Shahrzad Bazargan-Hejazi ^1,3 * , Ernesto Ramirez ¹, Senait Teklehaimanot ¹, Sara Diab ⁴, Maria Bangash ⁵, Magda Shaheen ^1,3

Cited by CrossRef: 2

1- Sagara K, Goto K, Maeda M, Murata F, Fukuda H. Medication adherence and associated factors in newly diagnosed hypertensive patients in Japan: the LIFE study. 2024;42(4):718 [Crossref]

2- Stanovska L, Krynytska I. ASSOCIATION OF ACHIEVEMENT/FAILURE OF THE TARGET LEVEL OF BLOOD PRESSURE AND ADHERENCE TO ANTIHYPERTENSIVE TREATMENT IN OUTPATIENTS WITH ISOLATED ARTERIAL HYPERTENSION AND IN COMBINATION WITH CARDIOVASCULAR COMORBIDITY. VPBM. 2024;1(1):253 [Crossref]

3- Ogura T, Shiraishi C. Comparison of Adverse Events Among Angiotensin Receptor Blockers in Hypertension Using the United States Food and Drug Administration Adverse Event Reporting System. 2025; [Crossref]

4- Arshed M, Kiran M, Umer M, Samkari J, hassan S, Qamer S, Gillani A, Hameed S, Ashraf W, Mujtaba H, Khan M. Prevalence and associated factors of adherence to antihypertensive medication: a nationwide cross-sectional study. BMC Public Health. 2025;25(1) [Crossref]